Abstract
Erythropoeitin is the most important factor in the regulation of erythropoeisis. This study aimed to evaluate the efficacy of rhuESF for patients undergoing plastic surgical procedures during which notable blood loss is expected (reduction mammoplasty in cases of macromastia and abdominoplasty obese patients) to improve the full blood count and reduce the need for transfusion. The levels of hemoglobin were significantly greater for patients pretreated with erythropoeitin and iron than for the control group.
Similar content being viewed by others
References
MF Almeida M Gerais (1999) ArticleTitlePreoperative normovolemic hemodilution in aesthetic plastic surgery. Aesth Plast Surg 23 445–449 Occurrence Handle10.1007/s002669900318 Occurrence Handle1:STN:280:DC%2BD3c%2Fps1CgtQ%3D%3D
Braga M: Erythropoietin and oncology including surgery. NATA, First Annual Meeting, Barcelona, January 31–February 1, 2000
J Cohen (1996) ArticleTitleIs blood transfusion necessary in reduction mammaplasty patients? Ann Plast Surg 37 161–118
Corcione A, Costagliola B, Della Gatta O et al: Utilizzo dell’Eritropoietina Umana Ricombinante negli Interventi di Chirurgia Addominale Oncologica. Atti Congresso Sicurezza in Anestesia. Napoli 15, 16 dic pp. 132–135, 2000
LT Goodnough TG Monk ME Brecher (1997) ArticleTitleAcute normovolemic hemodilution in surgery. Hematology 2 413–420
LT Goodnought (1998) ArticleTitleControversies in autolougous blood procurement. B. G. of Anaesthesia 81 IssueIDsuppl 1 .
W Jelkmann (1992) ArticleTitleErythropoietin: structure, control of production, and function. Physiol Rev 72 449–489 Occurrence Handle1:CAS:528:DyaK38XisVylsro%3D Occurrence Handle1557429
Keating M: Erythropoiesis and postoperative vigor: transfusion medicine and alternatives. NATA First Annual Meeting, Barcelona, January 31–February 1, 2000
S Marin-Bertolin JC Valia Vera R Gonzàlez-Martinez C Neira Gimènez J Amorrotu-Velayos (1998) ArticleTitleBlood loss and hematological recovery following reduction mammaplasty and dermolipectomy: a prospective study. Aesth Plast Surg 22 168–172 Occurrence Handle10.1007/s002669900186 Occurrence Handle1:STN:280:DyaK1c3oslGhug%3D%3D
Mercuriali F, Inghilleri G: Eritropoietina Umana Ricombinante (rhuEPO). Biologia e Clinica. ADIS International Limited, 1996
RB Noone WP Graham HP Royster (1973) ArticleTitleAutotransfusion for blood loss in some major esthetic operations. Plast Reconstr Surg 51 559–561 Occurrence Handle1:STN:280:CSyC28fmvFE%3D Occurrence Handle4701238
PM Paris RK Spence (1999) ArticleTitleThe predictive power of baseline hemoglobin for transfusion risk in surgery. Patients Orthop 22 IssueIDSuppl S135–S140
Samaha C: Erytropoietin and risk of thrombosis. NATA First Annual Meeting, Barcelona, January 31–February 1, 2000
SS Thomas S Srivastava JD Nancarrow MH Mohmand (1999) ArticleTitleDilute adrenaline infiltration blood loss in reduction mammaplasty. Ann Plast Surg 43 127–130 Occurrence Handle1:STN:280:DyaK1Mzot1Wiuw%3D%3D Occurrence Handle10454316
H Wilmink PHM Spauwen HM Hartman JC Hendriks VF Koeijers (1998) ArticleTitlePreoperative injection using a diluted anesthetic: adrenaline solution significantly reduces blood loss in reduction mammaplasty. Plast Reconstr Surg 102 373–376 Occurrence Handle1:STN:280:DyaK1czms1KgsA%3D%3D Occurrence Handle9703072
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ferraro, G.A., Corcione, A., Nicoletti, G.F. et al. The Use of Recombinant Human Erythropoeitin Stimulating Factor in Plastic Surgery. Aesth. Plast. Surg. 28, 174–176 (2004). https://doi.org/10.1007/s00266-003-3070-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-003-3070-6